SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: 777 Captain who wrote (21699)5/6/1999 6:28:00 PM
From: Little Gorilla  Read Replies (1) | Respond to of 23519
 
This month's Playboy has an article on ED drugs available now and on the horizon. The cover says "What's after Viagra?" and the article is called "Lifestyle Drugs". It starts out by stating that enthusiasm for Viagra has slowed, then mentions that the most commonly prescribed drugs after Viagra are Caverject, which is an injection, and Muse, which involves inserting a pellet. That means, the article states, that there is room for new drugs. The article then mentions the following drugs which may be available in the future:

Vasomax (ZONA)
Spontane (a sublingual)
IC-351 (ICOS)
a sublingual wafer version of Viagra, which PFE is now testing
Topiglan (MCHM's alprostadil gel)
Alprox-TD (another alprostadil gel)
*both of these last two companies plan to test their gels on "sexually challenged" females

The article has a table listing "What can you do now?" It lists Viagra, "unless you have heart problems", Caverject, "unless you hate needles", Muse, "unless you hate sticking a plastic tube up your penis".

Gene therapy is then discussed briefly. The article quotes Dr. Arnold Melman from Albert Einstein. Dr. Melman states that human testing of gene therapy for ED could begin as early as the end of 1999 with drugs on the market years after that.

(Someone read only part of the article to me over the phone so I apologize if anything I posted is inaccurate...)